产品档案由注册证、说明书原文与平台整理数据生成
Restylane Kysse Injectable GelP140029
Restylane Kysse Injectable Gel是一款玻尿酸填充产品,注册人 Q-Med AB。库里关联的注册证:美国 P140029。美国首次批准于 2016-12-09(P140029)。数据截至 2026-10-19。
- 监管属性玻尿酸填充 · 监管属性未定
- 注册人Q-Med AB
- 辖区US
- 档案更新于2026-10-19 · v1
注册与基本资料公开可看;交叉发现与价格需要登录
注册与基本资料
说明书对照(分辖区)
同一属性在不同辖区说明书里的原文;没写的标「原文未报告」,不适用的标「不适用」
暂无数据
注册时间线
- US
P140029 首次批准
- US
P140029 · P140029/S051
Normal 180 Day Track|Change Design/Components/Specifications/Material|Approval for (1) a new plastic syringe and new plunger, new plunger ro…
- US
P140029 · P140029/S055
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|approval for modifications to the Water for Injection (WFI) system
- US
P140029 · P140029/S054
Panel Track|Change Design/Components/Specifications/Material|Approval for expanding the indications of Restylane Contour for correction of t…
- US
P140029 · P140029/S056
30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Approval for extension of shelf life for the raw material sodium hy…
- US
P140029 · P140029/S057
Normal 180 Day Track No User Fee|Postapproval Study Protocol|Approval for the post-approval study protocol to evaluate the safety of re-trea…
- US
P140029 · P140029/S058
Normal 180 Day Track No User Fee|Labeling Change - PAS|approval for updated device labeling, including the addition of a statement regarding…
分开写首次批准、本证核发(延续或变更后会更新)、变更与有效期;首次批准为空表示未从官方来源取到。每张证只列最近 6 条变更,完整记录点编号看注册证原文。
交叉发现 · 价格观测
最近变化
5- P140029:Normal 180 Day Track No User Fee|Labeling Change - PAS|approval for updated devi…2026-09-18
- P140029:Normal 180 Day Track No User Fee|Postapproval Study Protocol|Approval for the po…2026-05-15
- P140029:30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|Approva…2026-04-14
- P140029:Panel Track|Change Design/Components/Specifications/Material|Approval for expand…2026-03-20
- P140029:30-Day Notice|Process Change - Manufacturer/Sterilizer/Packager/Supplier|approva…2025-09-26